Navigation Links
Med Discovery and Laborium Biopharma Sign a Bioprocess Development Partnership Agreement
Date:11/19/2008

Med Discovery S.A., a Swiss biotech firm and Laborium Biopharma, a subsidiary of Validapro Biosciences Inc. have signed a partnership agreement for the development and optimization of protein bioprocess production and scale-up.

Laval, Quebec (PRWEB) November 19, 2008 -- Med Discovery S.A., a Swiss biotech firm and Laborium Biopharma, a subsidiary of Validapro Biosciences Inc. have signed a partnership agreement for the development and optimization of protein bioprocess production and scale-up.

The first project pursued by the partners is Med Discovery's kallikrein inhibitor MDPK67b, a recombinant therapeutic protein which regulates different biological pathways involved in prostate cancer. The activity of MDPK67b has been validated in animal models of human prostate tumors.

Under the terms of this agreement, Laborium Biopharma will complete the bacterial production process and scale-up, and produce cGMP clinical material required to perform Phase I/IIa clinical trials.

Dr. David Deperthes, President and CEO at Med Discovery, commented: "This ambitious project requires a high level of technical expertise and top quality processes that meet the strictest regulatory standards. This collaboration is crucial, as it provides the platform for the development of our early-phase projects. We believe that Laborium Biopharma represents the ideal partner to help us successfully complete this critical phase of our MDPK67b development program."

Luc Dubois, President of Laborium Biopharma, said: "We are very pleased to collaborate with Med Discovery, a bright and innovative company and are proud of their trust in our capabilities. We will work diligently to help Med Discovery meet the strategic objective of testing its promising therapeutic protein in humans before the end of 2009."

Med Discovery S.A. is a private biopharmaceutical company headquartered in Geneva, Switzerland focusing on treatments for uro-genital cancers. The company is dedicated to the discovery and the development of highly specific protein drugs based on the optimization of natural proteins involved in the regulation of biological pathways. The company is leveraging a strong in-house expertise combined with an international network in clinical urology.

Laborium Biopharma is a private corporation based in the Biotechnology Research Institute of the National Research Council Canada in Montreal, Quebec. This new company is dedicated to the development and optimization of bio-production processes and the cGMP manufacturing of clinical batches of high-potency products.

###

Read the full story at http://www.prweb.com/releases/2008/11/prweb1641134.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Telik Announces New TRAP Drug Discovery Agreement
2. MaxCyte Hosts Live Discussion with Industry Experts on the Challenges in Developing Cell-Based Screening Assays for Drug Discovery
3. TIBCO Speeds Drug Discovery for Chemists
4. Global Drug Discovery Technologies Market to Exceed $57 Billion by 2012, According to a New Report by Global Industry Analysts
5. deCODE Discovery Sheds Light on Risk of the Most Common Form of Skin Cancer
6. Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline
7. The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline
8. Affitech Announces Second Milestone in Roche Antibody Discovery Collaboration
9. ChanTest to Highlight the Worlds Largest Catalog of Ion Channel-Expressing Cell Lines and Discovery Services at Assays & Cellular Targets Conference, Booth 11
10. Assay Designs(TM), Inc. and the Spinal Muscular Atrophy Foundation Announce Collaboration To Accelerate the Discovery of New Therapeutics for Spinal Muscular Atrophy (SMA)
11. Biotechnology & Drug Discovery Markets Push Up Demand for Lab Automation Products, According to a New Report by Global Industry Analysts
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Med Discovery and Laborium Biopharma Sign a Bioprocess Development Partnership Agreement
(Date:10/12/2017)... ... October 12, 2017 , ... They ... a complex biological network, a depiction of a system of linkages and connections ... Korkin, PhD, associate professor of computer science at Worcester Polytechnic Institute (WPI) and ...
(Date:10/12/2017)... ... October 12, 2017 , ... DuPont Pioneer ... that they have entered into a multiyear collaboration to identify and characterize novel ... additional tools for gene editing across all applications. , Under the terms of ...
(Date:10/12/2017)... ... October 12, 2017 , ... BioMedGPS ... the addition of its newest module, US Hemostats & Sealants. , SmartTRAK’s US ... absorbable hemostats, fibrin sealants, synthetic sealants and biologic sealants used in surgical applications. ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... platform specifically designed for life science researchers to analyze and interpret datasets, ... Franklin, who made a major contribution to the discovery of the double-helix ...
Breaking Biology Technology:
(Date:4/11/2017)... No two people are believed to ... York University Tandon School of Engineering and Michigan ... partial similarities between prints are common enough that ... and other electronic devices can be more vulnerable ... in the fact that fingerprint-based authentication systems feature ...
(Date:4/5/2017)... 4, 2017 KEY FINDINGS The ... at a CAGR of 25.76% during the forecast period ... primary factor for the growth of the stem cell ... MARKET INSIGHTS The global stem cell market ... and geography. The stem cell market of the product ...
(Date:3/30/2017)... Trends, opportunities and forecast in this market ... (fingerprint, AFIS, iris recognition, facial recognition, hand geometry, vein ... use industry (government and law enforcement, commercial and retail, ... others), and by region ( North America ... Pacific , and the Rest of the World) ...
Breaking Biology News(10 mins):